Oxidative stress in neurodegeneration

Advances in Pharmacological Sciences

Volumn 2011, Issue , 2011, Pages

  Shukla, Varsha ^a   Mishra, Santosh K ^b   Pant, Harish C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; CYCLIN DEPENDENT KINASE 5; FLAVONOID; FREE RADICAL; GLUTATHIONE PEROXIDASE; LEUCINE RICH REPEAT KINASE 2; MITOCHONDRIAL DNA; NUCLEAR RECEPTOR RELATED FACTOR 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; REACTIVE OXYGEN METABOLITE; RETINOL; SERINE PROTEINASE OMI; SUPEROXIDE DISMUTASE;

AEROBIC METABOLISM; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COGNITIVE DEFECT; DNA BINDING; ELECTRON TRANSPORT; HUMAN; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; NECROSIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN CONCENTRATION; OXYGEN CONSUMPTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; RNA BINDING; SIGNAL TRANSDUCTION;

EID: 81555225182     PISSN: 16876334     EISSN: 16876342     Source Type: Journal    
DOI: 10.1155/2011/572634     Document Type: Article

References (165)

1. Beal M. F., Mitochondria take center stage in aging and neurodegeneration Annals of Neurology 2005 58 4 495 505 (Pubitemid 41377212)
2. Hancock J. T., Desikan R., Neill S. J., Role of reactive oxygen species in cell signalling pathways Biochemical Society Transactions 2001 29 2 345 350 (Pubitemid 32587530)
3. Halliwell B., Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994 344 8924 721 724
4. Yu B. P., Cellular defenses against damage from reactive oxygen species Physiological Reviews 1994 74 1 139 162 (Pubitemid 24045676)
5. Poulsen H. E., Prieme H., Loft S., Role of oxidative DNA damage in cancer initiation and promotion European Journal of Cancer Prevention 1998 7 1 9 16 (Pubitemid 28164131)
6. Uday B., Dipak D., Ranajit B. K., Reactive oxygen species: oxidative damage and pathogenesis Current Science 1999 77 5 658 666
7. Lin M. T., Beal M. F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 2006 443 7113 787 795 (Pubitemid 44622683)
8. Saugstad O. D., Chronic lung disease: the role of oxidative stress Biology of the Neonate 1998 74 1 21 28 (Pubitemid 28425288)
9. Kennedy G., Spence V. A., McLaren M., Hill A., Underwood C., Belch J. J. F., Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms Free Radical Biology and Medicine 2005 39 5 584 589 (Pubitemid 41112100)
10. Trachtenberg B. H., Hare J. M., Biomarkers of oxidative stress in heart failure Heart Failure Clinics 2009 5 4 561 577
11. Rodrguez-Yez M., Castillo J., Role of inflammatory markers in brain ischemia Current Opinion in Neurology 2008 21 3 353 357 (Pubitemid 351653988)
12. Giugliano D., Ceriello A., Paolisso G., Oxidative stress and diabetic vascular complications Diabetes Care 1996 19 3 257 267 (Pubitemid 26070354)
13. Kinoshita J. H., Aldose reductase in the diabetic eye. XLIII Edward Jackson Memorial Lecture American Journal of Ophthalmology 1986 102 6 685 692 (Pubitemid 17196264)
14. Lyons T. J., Lipoprotein glycation and its metabolic consequences Diabetes 1992 41 2 67 73
15. Bowie A., Owens D., Collins P., Johnson A., Tomkin G. H., Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis 1993 102 1 63 67 (Pubitemid 23269731)
16. Baynes J. W., Role of oxidative stress in development of complications in diabetes Diabetes 1991 40 4 405 412
17. Nunomura A., Honda K., Takeda A., Hirai K., Zhu X., Smith M., Perry G., Oxidative damage to RNA in neurodegenerative diseases Journal of Biomedicine and Biotechnology 2006 2006 6
18. Perry G., Nunomura A., Hirai K., Zhu X., Prez M., Avila J., Castellani R. J., Atwood C. S., Aliev G., Sayre L. M., Takeda A., Smith M. A., Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radical Biology and Medicine 2002 33 11 1475 1479 (Pubitemid 35351590)
19. Selkoe D. J., Alzheimer's disease: genes, proteins, and therapy Physiological Reviews 2001 81 2 741 766 (Pubitemid 32267077)
20. O'Brien R. J., Wong P. C., Amyloid precursor protein processing and Alzheimers disease Annual Review of Neuroscience 2010 22 36 185 204
21. Zheng Y. L., Li B. S., Amin N. D., Albers W., Pant H. C., A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells European Journal of Biochemistry 2002 269 18 4427 4434
22. Hanger D. P., Betts J. C., Loviny T. L. F., Blackstock W. P., Anderton B. H., New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry Journal of Neurochemistry 1998 71 6 2465 2476 (Pubitemid 28531257)
23. Stoothoff W. H., Johnson G. V. W., Tau phosphorylation: physiological and pathological consequences Biochimica et Biophysica Acta 2005 1739 2 280 297 (Pubitemid 40018545)
24. Rudrabhatla P., Zheng Y. L., Amin N. D., Kesavapany S., Albers W., Pant H. C., Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein Journal of Biological Chemistry 2008 283 39 26737 26747
25. Lim J., Balastik M., Lee T. H., Nakamura K., Liou Y. C., Sun A., Finn G., Pastorino L., Lee V. M. Y., Lu K. P., Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy Journal of Clinical Investigation 2008 118 5 1877 1889 (Pubitemid 351632390)
26. Liou Y. C., Sun A., Ryo A., Zhou X. Z., Yu Z. X., Huang H. K., Uchida T., Bronson R., Bing G., Li X., Hunter T., Lu K. P., Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration Nature 2003 424 6948 556 561 (Pubitemid 36975777)
27. Iqbal K., Zaidi T., Bancher C., Grundke-Iqbal I., Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation FEBS Letters 1994 349 1 104 108
28. Iqbal K., Del C. Alonso A., Chen S., Chohan M. O., El-Akkad E., Gong C.-X., Khatoon S., Li B., Liu F., Rahman A., Tanimukai H., Grundke-Iqbal I., Tau pathology in Alzheimer disease and other tauopathies Biochimica et Biophysica Acta 2005 1739 2 198 210 (Pubitemid 40018538)
29. Keck S., Nitsch R., Grune T., Ullrich O., Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease Journal of Neurochemistry 2003 85 1 115 122 (Pubitemid 36389701)
30. Cras P., Smith M. A., Richey P. L., Siedlak S. L., Mulvihill P., Perry G., Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross linking in Alzheimer disease Acta Neuropathologica 1995 89 4 291 295
31. Smith M. A., Alzheimer disease International Review of Neurobiology 1998 42 1 54 (Pubitemid 128788937)
32. Shah R. S., Lee H.-G., Xiongwei Z., Perry G., Smith M. A., Castellani R. J., Current approaches in the treatment of Alzheimer's disease Biomedicine and Pharmacotherapy 2008 62 4 199 207 (Pubitemid 351635842)
33. Rowland L. P., Shneider N. A., Amyotrophic lateral sclerosis New England Journal of Medicine 2001 344 22 1688 1700 (Pubitemid 32479968)
34. Kikuchi S., Shinpo K., Ogata A., Tsuji S., Takeuchi M., Makita Z., Tashiro K., Detection of N -(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2002 3 2 63 68
35. Pedersen W. A., Fu W., Keller J. N., Markesbery W. R., Appel S., Smith R. G., Kasarskis E., Mattson M. P., Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients Annals of Neurology 1998 44 5 819 824 (Pubitemid 28516055)
36. Ferrante R. J., Browne S. E., Shinobu L. A., Bowling A. C., Baik M. J., MacGarvey U., Kowall N. W., Brown R. H., Beal M. F., Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis Journal of Neurochemistry 1997 69 5 2064 2074 (Pubitemid 27452754)
37. Barber S. C., Mead R. J., Shaw P. J., Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target Biochimica et Biophysica Acta 2006 1762 11-12 1051 1067 (Pubitemid 44750575)
38. Sayre L. M., Perry G., Smith M. A., Oxidative stress and neurotoxicity Chemical Research in Toxicology 2008 21 1 172 188 (Pubitemid 351219718)
39. Mattiazzi M., D'Aurelio M., Gajewski C. D., Martushova K., Kiaei M., Flint Beal M., Manfredi G., Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice Journal of Biological Chemistry 2002 277 33 29626 29633 (Pubitemid 41079252)
40. Kong J., Xu Z., Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1 Journal of Neuroscience 1998 18 9 3241 3250 (Pubitemid 28186017)
41. Liu J., Lillo C., Jonsson P. A., Velde C. V., Ward C. M., Miller T. M., Subramaniam J. R., Rothstein J. D., Marklund S., Andersen P. M., Brnnstrm T., Gredal O., Wong P. C., Williams D. S., Cleveland D. W., Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria Neuron 2004 43 1 5 17 (Pubitemid 38952815)
42. Estévez A. C., Crow J. P., Sampson J. B., Reiter C., Zhuang Y., Richardson G. J., Tarpey M. M., Barbeito L., Beckman J. S., Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase Science 1999 286 5449 2498 2500
43. Mattiazzi M., D'Aurelio M., Gajewski C. D., Martushova K., Kiaei M., Flint Beal M., Manfredi G., Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice Journal of Biological Chemistry 2002 277 33 29626 29633 (Pubitemid 41079252)
44. Rakhit R., Chakrabartty A., Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis Biochimica et Biophysica Acta 2006 1762 11-12 1025 1037 (Pubitemid 44781177)
45. Nordlund A., Oliveberg M., Folding of Cu/Zn superoxide dismutase suggests structural hotspots for gain of neurotoxic function in ALS: parallels to precursors in amyloid disease Proceedings of the National Academy of Sciences of the United States of America 2006 103 27 10218 10223 (Pubitemid 44051147)
46. Kabashi E., Durham H. D., Failure of protein quality control in amyotrophic lateral sclerosis Biochimica et Biophysica Acta 2006 1762 11-12 1038 1050 (Pubitemid 44750579)
47. Hart P. J., Pathogenic superoxide dismutase structure, folding, aggregation and turnover Current Opinion in Chemical Biology 2006 10 2 131 138
48. Okado-Matsumoto A., Fridovich I., Amyotrophic lateral sclerosis: a proposed mechanism Proceedings of the National Academy of Sciences of the United States of America 2002 99 13 9010 9014 (Pubitemid 34693674)
49. Pasinelli P., Belford M. E., Lennon N., Bacskai B. J., Hyman B. T., Trotti D., Brown R. H., Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria Neuron 2004 43 1 19 30 (Pubitemid 38952816)
50. Chang Y., Kong Q., Shan X., Tian G., Ilieva H., Cleveland D. W., Rothstein J. D., Borchelt D. R., Wong P. C., Lin C. L. G., Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS PLoS ONE 2008 3 8
51. Strong M. J., The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS) Journal of the Neurological Sciences 2010 288 1-2 1 12
52. Neumann M., Sampathu D. M., Kwong L. K., Truax A. C., Micsenyi M. C., Chou T. T., Bruce J., Schuck T., Grossman M., Clark C. M., McCluskey L. F., Miller B. L., Masliah E., Mackenzie I. R., Feldman H., Feiden W., Kretzschmar H. A., Trojanowski J. Q., Lee V. M. Y., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 2006 314 5796 130 133 (Pubitemid 44547757)
53. Wegorzewska I., Bell S., Cairns N. J., Miller T. M., Baloh R. H., TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration Proceedings of the National Academy of Sciences of the United States of America 2009 106 44 18809 18814
54. Gitcho M. A., Bigio E. H., Mishra M., Johnson N., Weintraub S., Mesulam M., Rademakers R., Chakraverty S., Cruchaga C., Morris J. C., Goate A. M., Cairns N. J., TARDBP 3′-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy Acta Neuropathologica 2009 118 5 633 645
55. Freibaum B. D., Chitta R. K., High A. A., Taylor J. P., Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery Journal of Proteome Research 2010 9 2 1104 1120
56. Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A., TDP-43 is recruited to stress granules in conditions of oxidative insult Journal of Neurochemistry 2009 111 4 1051 1061
57. Lagier-Tourenne C., Cleveland D. W., Rethinking ALS: the FUS about TDP-43 Cell 2009 136 6 1001 1004
58. Xu Y. F., Gendron T. F., Zhang Y. J., Lin W. L., D'Alton S., Sheng H., Casey M. C., Tong J., Knight J., Yu X., Rademakers R., Boylan K., Hutton M., McGowan E., Dickson D. W., Lewis J., Petrucelli L., Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice Journal of Neuroscience 2010 30 32 10851 10859
59. Jenner P., Hunot, Olanow, Beal, Kordower, Tatton, Schapira, Oxidative stress in Parkinson's disease Annals of Neurology 2003 53 3 S26 S38 (Pubitemid 36368560)
60. Kikuchi A., Takeda A., Onodera H., Kimpara T., Hisanaga K., Sato N., Nunomura A., Castellani R. J., Perry G., Smith M. A., Itoyama Y., Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy Neurobiology of Disease 2002 9 2 244 248 (Pubitemid 34261218)
61. Galloway P. G., Mulvihill P., Perry G., Filaments of Lewy bodies contain insoluble cytoskeletal elements American Journal of Pathology 1992 140 4 809 822
62. Hattori N., Mizuno P. Y., Pathogenetic mechanisms of parkin in Parkinson's disease Lancet 2004 364 9435 722 724 (Pubitemid 39140630)
63. Wood-Kaczmar A., Gandhi S., Wood N. W., Understanding the molecular causes of Parkinson's disease Trends in Molecular Medicine 2006 12 11 521 528 (Pubitemid 44633809)
64. Castellani R., Hirai K., Aliev G., Drew K. L., Nunomura A., Takeda A., Cash A. D., Obrenovich M. E., Perry G., Smith M. A., Role of mitochondrial dysfunction in Alzheimer's disease Journal of Neuroscience Research 2002 70 3 357 360 (Pubitemid 35222373)
65. Chalmers R. M., Brockington M., Howard R. S., Lecky B. R. F., Morgan-Hughes J. A., Harding A. E., Mitochondrial encephalopathy with multiple mitochondrial DNA deletions: a report of two families and two sporadic cases with unusual clinical and neuropathological features Journal of the Neurological Sciences 1996 143 1-2 41 45 (Pubitemid 26402784)
66. Siciliano G., Mancuso M., Ceravolo R., Lombardi V., Iudice A., Bonuccelli U., Mitochondrial DNA rearrangements in young onset parkinsonismml: two case reports Journal of Neurology Neurosurgery and Psychiatry 2001 71 5 685 687 (Pubitemid 33010588)
67. De Coo I. F. M., Renier W. O., Ruitenbeek W., Ter Laak H. J., Bakker M., Schgger H., Van Oost B. A., Smeets H. J. M., A 4-base pair deletion in the mitochondrial cytochrome b gene associated with Parkinsonism/MELAS overlap syndrome Annals of Neurology 1999 45 1 130 133 (Pubitemid 29036443)
68. Thyagarajan D., Bressman S., Bruno C., Przedborski S., Shanske S., Lynch T., Fahn S., Dimauro S., A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy Annals of Neurology 2000 48 5 730 736
69. Zhou W., Huribert M. S., Schaack J., Prasad K. N., Freed C. R., Overexpression of human -synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells Brain Research 2000 866 1-2 33 43 (Pubitemid 30313005)
70. Lee M., Hyun D. H., Halliwell B., Jenner P., Effect of the overexpression of wild-type or mutant -synuclein on cell susceptibility to insult Journal of Neurochemistry 2001 76 4 998 1009 (Pubitemid 32167373)
71. Giasson B. I., Forman M. S., Higuchi M., Golbe L. I., Graves C. L., Kotzbauer P. T., Trojanowski J. Q., Lee V. M. Y., Initiation and synergistic fibrillization of tau and alpha-synuctein Science 2003 300 5619 636 640 (Pubitemid 36520587)
72. Iseki E., Marui W., Kosaka K., Uéda K., Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease Neuroscience Letters 1999 265 1 9 12 (Pubitemid 29210185)
73. Lee V. M. Y., Giasson B. I., Trojanowski J. Q., More than just two peas in a pod: common amyloidogenic properties of tau and -synuclein in neurodegenerative diseases Trends in Neurosciences 2004 27 3 129 134 (Pubitemid 38251512)
74. Dawson T. M., Dawson V. L., Molecular pathways of neurodegeneration in Parkinson's disease Science 2003 302 5646 819 822 (Pubitemid 37339614)
75. Schapira A. H., Causes of neuronal death in Parkinson's disease Advances in neurology 2001 86 155 162
76. Beal M. F., Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment Journal of Bioenergetics and Biomembranes 2004 36 4 381 386 (Pubitemid 39619845)
77. Keeney P. M., Xie J., Capaldi R. A., Bennett J. P. Jr., Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled Journal of Neuroscience 2006 26 19 5256 5264 (Pubitemid 44315308)
78. Sanchez-Ramos J., Overvik E., Ames B., A marker of oxyradical-mediated DNA damage (8-hydroxy- 2′ -deoxyguanosine) is increased in nigro-striatum of Parkinsons disease brain Neurodegeneration 1994 3 197 204
79. Zhang J., Perry G., Smith M. A., Robertson D., Olson S. J., Graham D. G., Montine T. J., Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons American Journal of Pathology 1999 154 5 1423 1429 (Pubitemid 29226437)
80. Alam Z. I., Daniel S. E., Lees A. J., Marsden D. C., Jenner P., Halliwell B., A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease Journal of Neurochemistry 1997 69 3 1326 1329 (Pubitemid 27364859)
81. Floor E., Wetzel M. G., Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay Journal of Neurochemistry 1998 70 1 268 275 (Pubitemid 28020852)
82. Good P. F., Hsu A., Werner P., Perl D. P., Warren Olanow C., Protein nitration in Parkinson's disease Journal of Neuropathology and Experimental Neurology 1998 57 4 338 342 (Pubitemid 28182632)
83. Castellani R., Smith M. A., Richey P. L., Perry G., Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease Brain Research 1996 737 1-2 195 200 (Pubitemid 26366614)
84. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R., Mizuno Y., Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease Proceedings of the National Academy of Sciences of the United States of America 1996 93 7 2696 2701 (Pubitemid 26114311)
85. Castellani R. J., Perry G., Siedlak S. L., Nunomura A., Shimohama S., Zhang J., Montine T., Sayre L. M., Smith M. A., Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans Neuroscience Letters 2002 319 1 25 28 (Pubitemid 34117635)
86. Fredenburg R. A., Rospigliosi C., Meray R. K., Kessler J. C., Lashuel H. A., Eliezer D., Lansbury P. T. Jr., The impact of the E46K mutation on the properties of -synuclein in its monomelic and oligomeric states Biochemistry 2007 46 24 7107 7118 (Pubitemid 46973985)
87. Song D. D., Shults C. W., Sisk A., Rockenstein E., Masliah E., Enhanced substantia nigra mitochondrial pathology in human -synuclein transgenic mice after treatment with MPTP Experimental Neurology 2004 186 2 158 172 (Pubitemid 38333191)
88. Klivenyi P., Siwek D., Gardian G., Yang L., Starkov A., Cleren C., Ferrante R. J., Kowall N. W., Abeliovich A., Beal M. F., Mice lacking alpha-synuclein are resistant to mitochondrial toxins Neurobiology of Disease 2006 21 3 541 548 (Pubitemid 43277537)
89. McNaught K. S. P., Belizaire R., Isacson O., Jenner P., Olanow C. W., Altered proteasomal function in sporadic Parkinson's disease Experimental Neurology 2003 179 1 38 46 (Pubitemid 36062617)
90. Pesah Y., Pham T., Burgess H., Middlebrooks B., Verstreken P., Zhou Y., Harding M., Bellen H., Mardon G., Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress Development 2004 131 9 2183 2194 (Pubitemid 38702049)
91. Palacino J. J., Sagi D., Goldberg M. S., Krauss S., Motz C., Wacker M., Klose J., Shen J., Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice Journal of Biological Chemistry 2004 279 18 18614 18622 (Pubitemid 38623283)
92. Bonifati V., Rizzu P., Van Baren M. J., Schaap O., Breedveld G. J., Krieger E., Dekker M. C. J., Squitieri F., Ibanez P., Joosse M., Van Dongen J. W., Vanacore N., Van Swieten J. C., Brice A., Meco G., Van Duijn C. M., Oostra B. A., Heutink P., Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 2003 299 5604 256 259 (Pubitemid 36131051)
93. Kim R. H., Smith P. D., Aleyasin H., Hayley S., Mount M. P., Pownall S., Wakeham A., You-Ten A. J., Kalia S. K., Horne P., Westaway D., Lozano A. M., Anisman H., Park D. S., Mak T. W., Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyrindine (MPTP) and oxidative stress Proceedings of the National Academy of Sciences of the United States of America 2005 102 14 5215 5220
94. Meulener M. C., Xu K., Thompson L., Ischiropoulos H., Bonini N. M., Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging Proceedings of the National Academy of Sciences of the United States of America 2006 103 33 12517 12522 (Pubitemid 44267290)
95. Valente E. M., Abou-Sleiman P. M., Caputo V., Muqit M. M. K., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A. R., Healy D. G., Albanese A., Nussbaum R., Gonzlez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W. P., Latchman D. S., Harvey R. J., Dallapiccola B., Auburger G., Wood N. W., Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 2004 304 5674 1158 1160 (Pubitemid 38661852)
96. Petit A., Kawarai T., Paitel E., Sanjo N., Maj M., Scheid M., Chen F., Gu Y., Hasegawa H., Salehi-Rad S., Wang L., Rogaeva E., Fraser P., Robinson B., George -. P. S., Tandon A., Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations Journal of Biological Chemistry 2005 280 40 34025 34032 (Pubitemid 41443124)
97. Jones D. C., Gunasekar P. G., Borowitz J. L., Isom G. E., Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells Journal of Neurochemistry 2000 74 6 2296 2304 (Pubitemid 30314204)
98. Napolitano A., Crescenzi O., Pezzella A., Prota G., Generation of the neurotoxin 6-hydroxydopamine by peroxidase/H2O2 oxidation of dopamine Journal of Medicinal Chemistry 1995 38 6 917 922
99. Imam S. Z., El-Yazal J., Newport G. D., Itzhak Y., Cadet J. L., Slikker W., Ali S. F., Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts Annals of the New York Academy of Sciences 2001 939 366 380 (Pubitemid 32620088)
100. Gtz M. E., Double K., Gerlach M., Youdim M. B. H., Riederer P., The relevance of iron in the pathogenesis of Parkinson's disease Annals of the New York Academy of Sciences 2004 1012 193 208 (Pubitemid 38455479)
101. Kaur D., Andersen J., Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Research Reviews 2004 3 3 327 343 (Pubitemid 38844698)
102. Davies S., Ramsden D. B., Huntington's disease Journal of Clinical Pathology 2001 54 6 409 413 (Pubitemid 34025256)
103. Gusella J. F., Wexler N. S., Conneally P. M., A polymorphic DNA marker genetically linked to Huntington's disease Nature 1983 306 5940 234 238 (Pubitemid 14232350)
104. Rego A. C., Oliveira C. R., Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases Neurochemical Research 2003 28 10 1563 1574 (Pubitemid 37193539)
105. Gusella J. F., McDonald M. E., Huntingtons disease Seminars in Cell Biology 1995 6 21 28
106. Browne S. E., Bowling A. C., MacGarvey U., Baik M. J., Berger S. C., Muqit M. M. K., Bird E. D., Beal M. F., Oxidative damage and metabolic dysfunction in huntington's disease: selective vulnerability of the basal ganglia Annals of Neurology 1997 41 5 646 653 (Pubitemid 27212659)
107. Jenkins B. G., Koroshetz W. J., Beal M. F., Rosen B. R., Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy Neurology 1993 43 12 I 2689 2695 (Pubitemid 24004570)
108. Koroshetz W. J., Jenkins B. G., Rosen B. R., Flint Beal M., Energy metabolism defects in Huntington's disease and effects of coenzyme Q10 Annals of Neurology 1997 41 2 160 165 (Pubitemid 27082096)
109. Parker W. D., Boyson S. J., Luder A. S., Parks J. K., Evidence for a defect in NADH:ubiquinone oxidoreductase (complex I) in Huntington's disease Neurology 1990 40 8 1231 1234 (Pubitemid 20244981)
110. Butterworth J., Yates C. M., Reynolds G. P., Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and -glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases Journal of the Neurological Sciences 1985 67 2 161 171 (Pubitemid 15130758)
111. Mann V. M., Cooper J. M., Javoy-Agid F., Agid Y., Jenner P., Schapira A. H.V., Mitochondrial function and parental sex effect in Huntington's disease Lancet 1990 336 8717 749 (Pubitemid 20309171)
112. Goebel H. H., Heipertz R., Scholz W., Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies Neurology 1978 28 1 23 31 (Pubitemid 8272515)
113. Grdin G., Vécsei L., Huntington's disease: pathomechanism and therapeutic perspectives Journal of Neural Transmission 2004 111 10-11 1485 1494 (Pubitemid 39468401)
114. Del Hoyo P., Garca-Redondo A., De Bustos F., Molina J. A., Sayed Y., Alonso-Navarro H., Caballero L., Arenas J., Jiménez-Jiménez F. J., Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease Neurochemical Research 2006 31 9 1103 1109 (Pubitemid 44379670)
115. Milakovic T., Johnson G. V. W., Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin Journal of Biological Chemistry 2005 280 35 30773 30782 (Pubitemid 41291807)
116. Li B.-S., Zhang L., Gu J., Amin N. D., Pant H. C., Integrin 1 1-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation Journal of Neuroscience 2000 20 16 6055 6062 (Pubitemid 30658399)
117. Smith D. S., Tsai L. H., Cdk5 behind the wheel: a role in trafficking and transport? Trends in Cell Biology 2002 12 1 28 36 (Pubitemid 34164154)
118. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M., Tsai L. H., Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 2000 405 6784 360 364 (Pubitemid 30337070)
119. Dhavan R., Tsai L. H., A decade of CDK5 Nature Reviews Molecular Cell Biology 2001 2 10 749 759 (Pubitemid 33679837)
120. Amin N. D., Albers W., Pant H. C., Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35 Journal of Neuroscience Research 2002 67 3 354 362 (Pubitemid 34137142)
121. Tsai L. H., Delalle I., Caviness V. S., Chae T., Harlow E., p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 Nature 1994 371 6496 419 423 (Pubitemid 24302556)
122. Patrick G. N., Zukerberg L., Nikolic M., De La Monte S., Dikkes P., Tsai L. H., Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 1999 402 6762 615 622 (Pubitemid 129516324)
123. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M., Tsai L. H., Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 2000 405 6784 360 364 (Pubitemid 30337070)
124. Strocchi P., Pession A., Dozza B., Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells Journal of Cellular Biochemistry 2003 88 4 758 765 (Pubitemid 36258825)
125. Cruz J. C., Tsai L. H., Cdk5 deregulation in the pathogenesis of Alzheimer's disease Trends in Molecular Medicine 2004 10 9 452 458 (Pubitemid 39209212)
126. Quintanilla R. A., Orellana D. I., Gonzlez-Billault C., Maccioni R. B., Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway Experimental Cell Research 2004 295 1 245 257 (Pubitemid 38407361)
127. Shea T. B., Zheng Y. L., Ortiz D., Pant H. C., Cyclin-dependent kinase 5 increases perikaryal neurofilament phosphorylation and inhibits neurofilament axonal transport in response to oxidative stress Journal of Neuroscience Research 2004 76 6 795 800 (Pubitemid 38720686)
128. Kitazawa M., Oddo S., Yamasaki T. R., Green K. N., LaFerla F. M., Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease Journal of Neuroscience 2005 25 39 8843 8853 (Pubitemid 41384452)
129. Patzke H., Tsai L. H., Cdk5 sinks into ALS Trends in Neurosciences 2002 25 1 8 10 (Pubitemid 34093773)
130. Tseng H. C., Zhou Y., Shen Y., Tsai L. H., A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains FEBS Letters 2002 523 13 58 62 (Pubitemid 34786058)
131. Lee M. S., Tsai L. H., Cdk5: one of the links between senile plaques and neurofibrillary tangles? Journal of Alzheimer's Disease 2003 5 2 127 137
132. De La Monte S. M., Ganju N., Feroz N., Luong T., Banerjee K., Cannon J., Wands J. R., Oxygen free radical injury is sufficient to cause some Alzheimer-type molecular abnormalities in human CNS neuronal cells Journal of Alzheimer's Disease 2000 2 3-4 261 281 (Pubitemid 32095611)
133. Hashiguchi M., Saito T., Hisanaga S.-I., Hashiguchi T., Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau Journal of Biological Chemistry 2002 277 46 44525 44530 (Pubitemid 36157887)
134. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E. K., Jones P. K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C. S., Petersen R. B., Smith M. A., Oxidative damage is the earliest event in Alzheimer disease Journal of Neuropathology and Experimental Neurology 2001 60 8 759 767 (Pubitemid 32678256)
135. Kesavapany S., Zheng Y. L., Amin N., Pant H. C., Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5 Biotechnology Journal 2007 2 8 978 987 (Pubitemid 47377105)
136. Zheng Y. L., Kesavapany S., Gravell M., Hamilton R. S., Schubert M., Amin N., Albers W., Grant P., Pant H. C., A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons EMBO Journal 2005 24 1 209 220 (Pubitemid 40188478)
137. Sun K. H., De Pablo Y., Vincent F., Shah K., Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction Journal of Neurochemistry 2008 107 1 265 278
138. Chang K. H., De Pablo Y., Lee H. P., Lee H. G., Smith M. A., Shah K., Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease Journal of Neurochemistry 2010 113 5 1221 1229
139. Pei J. J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., Cowburn R. F., Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration Journal of Alzheimer's Disease 2001 3 1 41 48 (Pubitemid 32238249)
140. Zhu X., Rottkamp C. A., Hartzler A., Sun Z., Takeda A., Boux H., Shimohama S., Perry G., Smith M. A., Activation of MKK6, an upstream activator of p38, in Alzheimer's disease Journal of Neurochemistry 2001 79 2 311 318 (Pubitemid 32988947)
141. Mizusawa H., Ishii T., Bannai S., Peroxiredoxin I (macrophage 23 kDa stress protein) is highly and widely expressed in the rat nervous system Neuroscience Letters 2000 283 1 57 60 (Pubitemid 30146735)
142. Chang T. S., Jeong W., Choi S. Y., Yu S., Kang S. W., Rhee S. G., Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation Journal of Biological Chemistry 2002 277 28 25370 25376 (Pubitemid 34951848)
143. Kang S. W., Rhee S. G., Chang T. S., Jeong W., Choi M. H., 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic
144. Veal E. A., Day A. M., Morgan B. A., Hydrogen peroxide sensing and signaling Molecular Cell 2007 26 1 1 14 (Pubitemid 46578115)
145. Piedrahita D., Hernndez I., Lpez-Tobn A., Fedorov D., Obara B., Manjunath B. S., Boudreau R. L., Davidson B., LaFerla F., Gallego-Gmez J. C., Kosik K. S., Cardona-Gmez G. P., Silencing of CDK5 reduces neurofibrillary tangles in transgenic Alzheimer's mice Journal of Neuroscience 2010 30 42 13966 13976
146. Iijima K.-I., Ando K., Takeda S., Satoh Y., Seki T., Itohara S., Greengard P., Kirino Y., Nairn A. C., Suzuki T., Neuron-specific phosphorylation of Alzheimer's -amyloid precursor protein by cyclin-dependent kinase 5 Journal of Neurochemistry 2000 75 3 1085 1091 (Pubitemid 30660497)
147. Cruz J. C., Tseng H. C., Goldman J. A., Shih H., Tsai L. H., Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles Neuron 2003 40 3 471 483 (Pubitemid 37494698)
148. Pant A. C., Veeranna, Pant H. C., Amin N., Phosphorylation of human high molecular weight neurofilament protein (hNF-H) by neuronal cyclin-dependent kinase 5 (cdk5) Brain Research 1997 765 2 259 266 (Pubitemid 27397621)
149. Sharma M., Sharma P., Pant H. C., CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells Journal of Neurochemistry 1999 73 1 79 86 (Pubitemid 29289113)
150. Grant P., Sharma P., Pant H. C., Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism European Journal of Biochemistry 2001 268 6 1534 1546 (Pubitemid 32862685)
151. Cookson M. R., Shaw P. J., Oxidative stress and motor neurone disease Brain Pathology 1999 9 1 165 186 (Pubitemid 29056526)
152. Strong M., The basics of therapeutics in amyotrophic lateral sclerosis Pharmacology Therapeutics 2003 5542 1 36
153. Nguyen M. D., Larivire R. C., Julien J. P., Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions Neuron 2001 30 1 135 147 (Pubitemid 32441682)
154. Rao M. V., Nixon R. A., Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review Neurochemical Research 2003 28 7 1041 1047 (Pubitemid 36576201)
155. Alvira D., Ferrer I., Gutierrez-Cuesta J., Garcia-Castro B., Palls M., Camins A., Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease Parkinsonism and Related Disorders 2008 14 4 309 313 (Pubitemid 351726515)
156. Avraham E., Rott R., Liani E., Szargel R., Engelender S., Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation Journal of Biological Chemistry 2007 282 17 12842 12850 (Pubitemid 47100582)
157. Kazantsev A., Walker H. A., Slepko N., Bear J. E., Preisinger E., Steffan J. S., Zhu Y. Z., Gertler F. B., Housman D. E., Marsh J. L., Thompson L. M., A bivalent Huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila Nature Genetics 2002 30 4 367 376
158. Snchez I., Mahlke C., Yuan J., Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders Nature 2003 421 6921 373 379 (Pubitemid 36157935)
159. Goldberg Y. P., Nicholson D. W., Rasper D. M., Kalchman M. A., Koide H. B., Graham R. K., Bromm M., Kazemi-Esfarjani P., Thornberry N. A., Vaillancourt J. P., Hayden M. R., Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract Nature Genetics 1996 13 4 442 449 (Pubitemid 26256618)
160. Wellington C. L., Singaraja R., Ellerby L., Savill J., Roy S., Leavitt B., Cattaneo E., Hackam A., Sharp A., Thornberry N., Nicholson D. W., Bredesen D. E., Hayden M. R., Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells Journal of Biological Chemistry 2000 275 26 19831 19838 (Pubitemid 30441585)
161. Kim Y. J., Yi Y., Sapp E., Wang Y., Cuiffo B., Kegel K. B., Qin Z. H., Aronin N., DiFiglia M., Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpaindependent proteolysis Proceedings of the National Academy of Sciences of the United States of America 2001 98 22 12784 12789 (Pubitemid 33020022)
162. Lunkes A., Lindenberg K. S., Ben-Haem L., Weber C., Devys D., Landwehrmeyer G. B., Mandel J. L., Trottier Y., Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions Molecular Cell 2002 10 2 259 269 (Pubitemid 35007341)
163. Luo S., Vacher C., Davies J. E., Rubinsztein D. C., Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity Journal of Cell Biology 2005 169 4 647 656 (Pubitemid 41002857)
164. Anne S. L., Saudou F., Humbert S., Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons Journal of Neuroscience 2007 27 27 7318 7328 (Pubitemid 47037570)
165. Kaminosono S., Saito T., Oyama F., Ohshima T., Asada A., Nagai Y., Nukina N., Hisanaga S. I., Suppression of mutant huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability Journal of Neuroscience 2008 28 35 8747 8755